Crossmark

Clinical impact of preoperative serum p53 antibody titers in 1487 patients with surgically treated esophageal squamous cell carcinoma: a multi-institutional study

Crossref DOI link: https://doi.org/10.1007/s10388-020-00761-6

Published Online: 2020-07-26

Published Print: 2021-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Takashi, Suzuki

Satoshi, Yajima

Akihiko, Okamura

Naoya, Yoshida

Yusuke, Taniyama

Kentaro, Murakami

Yu, Ohkura

Yasuaki, Nakajima

Koichi, Yagi

Takashi, Fukuda

Ryo, Ogawa

Isamu, Hoshino

Chikara, Kunisaki

Kosuke, Narumiya

Yasuhiro, Tsubosa

Kazuhiko, Yamada

Hideaki, Shimada https://orcid.org/0000-0002-1990-8217
License Information

Text and Data Mining valid from 2020-07-26

Version of Record valid from 2020-07-26
More Information

Article History

Received: 29 May 2020

Accepted: 17 July 2020

First Online: 26 July 2020

Compliance with ethical standards

:

: This retrospective study was approved by the Institutional Ethics Committee of Toho University (Tokyo, Japan; IRB #A18112_A17044_A16037).

: Hideaki Shimada received a research fund from Medical and Biological Laboratories. Ltd. The other authors declare that they have no conflicts of interest.

: This retrospective study was approved by the Institutional Ethics Committee of Toho University (Tokyo, Japan; IRB #A18112_A17044_A16037).

Document is current

Any future updates will be listed below